The role of c-Myc in Epstein-Barr virus-associated cancers: Mechanistic insights and therapeutic implications.
1/5 보강
c-Myc is an important proto-oncogene belonging to the MYC family.
APA
Mahdavi P, Panahipoor Javaherdehi A, et al. (2024). The role of c-Myc in Epstein-Barr virus-associated cancers: Mechanistic insights and therapeutic implications.. Microbial pathogenesis, 197, 107025. https://doi.org/10.1016/j.micpath.2024.107025
MLA
Mahdavi P, et al.. "The role of c-Myc in Epstein-Barr virus-associated cancers: Mechanistic insights and therapeutic implications.." Microbial pathogenesis, vol. 197, 2024, pp. 107025.
PMID
39426639 ↗
Abstract 한글 요약
c-Myc is an important proto-oncogene belonging to the MYC family. In normal conditions, c-Myc regulates different aspects of cellular function. However, its dysregulation can result in the development of cancer due to various mechanisms. Epstein-Barr virus is a ubiquitous viral pathogen that infects a huge proportion of the global population. This virus is linked to various cancers, such as different types of lymphoma, nasopharyngeal, and gastric cancers. It can manipulate host cells, and many cellular and viral genes are important in the Epstein-Barr virus carcinogenesis. This review explores the complex relationship between c-Myc and Epstein-Barr virus in the context of cancer development. Also, potential therapeutic strategies targeting c-Myc to treat EBV-related cancers are discussed.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.